- What is Ironwood Pharmaceuticals, Inc. - Class A's Market Cap?
- Ironwood Pharmaceuticals, Inc. - Class A's Market Cap is $796.3M, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E?
- Ironwood Pharmaceuticals, Inc. - Class A's Trailing P/E is 5.3×, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales?
- Ironwood Pharmaceuticals, Inc. - Class A's Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM)?
- Ironwood Pharmaceuticals, Inc. - Class A's Revenue (TTM) is $400.3M, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM)?
- Ironwood Pharmaceuticals, Inc. - Class A's Net Income (TTM) is $149.6M, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA?
- Ironwood Pharmaceuticals, Inc. - Class A's EBITDA is $252.9M, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM)?
- Ironwood Pharmaceuticals, Inc. - Class A's Diluted EPS (TTM) is 0.90, based on as-reported figures from SEC (XBRL) filings.
- What is Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin?
- Ironwood Pharmaceuticals, Inc. - Class A's EBITDA Margin is 63.2%, based on as-reported figures from SEC (XBRL) filings.